Adenocarcinoma of the Esophagus Terminated Phase 1 / 2 Trials for Carboplatin (DB00958)

IndicationStatusPhase
DBCOND0030040 (Adenocarcinoma of the Esophagus)Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01395537Lapatinib With Carboplatin and Paclitaxel in Esophagus and Gastroesophageal Junction (GEJ)Treatment